Success Stories: We Well-Aided a New-Jersey based Associate Scientist from India in the Field of Immunotherapy to Achieve a Green Card Along with the EB-1A Approval
Client’s Testimonial:
“Thank you so much! I would like to thank Ms. Rachel and everyone involved in Chen Immigration Team for their brilliant work! you guys did an amazing job with reference letters and PL. Moreover, thank you for answering all my doubts and questions throughout the whole process. I am absolutely thrilled. Thank you, everyone!!”
On February 2nd, 2022, we received another EB-1A (Alien of Extraordinary Ability) approval for an Associate Scientist in the field of Immunotherapy (Approval Notice).
General Field: Immunotherapy
Position at the Time of Case Filing: Associate Scientist
Country of Origin: India
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: February 2nd, 2022
Processing Time: 8 days (Premium Processing Requested)
Case Summary:
Our client’s qualification, experience, expertise, history of publication and citation records, and documented evidence of her successful research in the field of immunotherapy, all exhibit that she is well-positioned to advance the proposed endeavor. We are delighted that our diligence, in this case, paid off well in demonstrating that our client’s innovative contributions in her field of expertise prove that she is worthy of advancing her work here in the United States. She will undoubtedly continue to lead in her research field and contribute to the development of novel cancer treatments in the USA. Thus, she secured her I-140 EB1A (Alien of Extraordinary Ability) petition approval in just 8 days, thanks to the premium processing service as well.
Our team at North America Immigration Law Group is an expert in curating EB1A petition packets. Thus, when our client approached us, we intended to affirm that she is one of the few experts who has achieved records of success and acclaim this recognition by her admirable publication and citation records in the field of immunotherapy. We noted that her work (6 peer-reviewed scientific articles) has been cited 1,088 times, a laudable total indicating the international appeal of her research. This praise-worthy citation record shows that hundreds of scholars in immunotherapy and other related disciplines have turned to her research as a reliable source of information and have used her findings to inform and advance their projects.
Besides, it is a noteworthy achievement for a scientist to be asked to judge the work of his or her peers, and the fact that our client has been invited to peer review multiple articles for respected journals. She has at least conducted 19 peer reviews which proves that she is internationally recognized as a leading immunotherapy researcher.
Moreover, we detailed our client’s work related to the discovery of unique anti-cancer drugs to treat targeted cancer patient populations, addressing some of our nation’s and the world’s most pressing issues, including the need for improved cancer treatments.
To bolster our client’s case further, we added recommendation letters signed by four other expert scholars in the field, one of whom stated:
“…Within this area of research, [client] is a leading expert who has made crucial strides forward in the understanding of the relationship between immunotherapy and the tumor microenvironment. Since cancer is a major public health and economic issue around the world, causing nearly 10 million deaths every year, the value of [clients’] research truly cannot be overstated.”
We are glad that our client achieved her EB1A approval, and we are ecstatic that she retained us for her I-485 application and grabbed the green card just four months after her EB1A approval. Therefore, we wish her the best of luck in all her future endeavors.